Mark Sullivan
Founder at Medicines Development for Global Health Ltd
Mark Sullivan active positions
| Companies | Position | Start | End |
|---|---|---|---|
Medicines Development for Global Health Ltd
 Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Director/Board Member | - | - |
| Chief Executive Officer | 01/10/2005 | - | |
| Founder | 01/10/2005 | - | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Private Equity Investor | 01/07/2020 | - |
| Global Health Funds LLC | Consultant / Advisor | 01/12/2020 | - |
Career history of Mark Sullivan
Former positions of Mark Sullivan
| Companies | Position | Start | End |
|---|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 18/02/2011 | 15/12/2012 |
| University of New South Wales Built Environment | Chief Operating Officer | 01/03/2003 | 30/09/2005 |
| GILEAD SCIENCES, INC. | Director/Board Member | 01/01/2001 | 31/12/2003 |
i3 Global
 i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Director/Board Member | 01/11/1999 | 31/12/2000 |
Training of Mark Sullivan
| Deakin University | Undergraduate Degree |
Statistics
International
| Australia | 5 |
| United States | 5 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Medicines Development for Global Health Ltd
Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
| Global Health Funds LLC | |
i3 Global
i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Commercial Services |
- Stock Market
- Insiders
- Mark Sullivan
- Experience
